Lionco Pharmaceutical Group Co.,Ltd.

Rachunek Zysków i Strat


Statystyki
Dywidendy
Rekomendacje
Wyceny
Wskaźniki
Analiza techniczna



Przychody TTM (mln): 276
EBIT TTM (mln): -133
index 0 1 2 3 4 5 6 7 8 9 10 11 12 13
Rok finansowy 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Przychód (mln) 272 468 494 576 551 479 1,005 1,669 1,635 1,001 740 289 197 380
Przychód Δ r/r 0.0% 72.4% 5.5% 16.6% -4.5% -13.1% 110.0% 66.1% -2.1% -38.8% -26.0% -60.9% -32.0% 92.9%
Marża brutto 44.9% 61.3% 59.1% 60.9% 60.0% 57.7% 80.0% 87.9% 86.4% 84.5% 79.4% 67.8% 46.7% 46.9%
EBIT (mln) 65 124 130 164 172 131 182 209 223 181 71 -164 -149 -129
EBIT Δ r/r 0.0% 89.9% 4.7% 26.1% 5.2% -24.2% 39.3% 14.9% 6.5% -18.8% -60.6% -330.7% -9.2% -13.6%
EBIT (%) 24.1% 26.5% 26.3% 28.4% 31.3% 27.3% 18.1% 12.5% 13.6% 18.1% 9.6% -56.7% -75.7% -33.9%
Koszty finansowe (mln) -0 0 0 0 5 0 0 2 14 11 16 6 4 27
EBITDA (mln) 63 148 142 214 212 209 218 241 273 237 137 -121 -67 -64
EBITDA(%) 23.3% 31.7% 28.7% 37.1% 38.6% 43.6% 21.7% 14.4% 16.7% 23.7% 18.5% -41.9% -34.1% -16.9%
Podatek (mln) 17 40 38 35 27 23 19 21 21 19 5 7 1 3
Zysk Netto (mln) 56 95 115 150 150 154 161 183 202 160 66 -196 -151 -131
Zysk netto Δ r/r 0.0% 70.7% 20.6% 30.5% -0.1% 2.8% 4.6% 13.5% 10.3% -20.6% -58.8% -397.0% -22.6% -13.7%
Zysk netto (%) 20.5% 20.3% 23.2% 26.0% 27.2% 32.2% 16.0% 10.9% 12.3% 16.0% 8.9% -67.7% -77.0% -34.4%
EPS 0.41 0.18 0.22 0.28 0.23 0.22 0.22 0.26 0.28 0.22 0.0921 -0.27 -0.21 -0.18
EPS (rozwodnione) 0.41 0.18 0.22 0.28 0.23 0.22 0.22 0.26 0.28 0.21 0.0851 -0.27 -0.21 -0.18
Ilośc akcji (mln) 721 533 534 534 639 713 713 711 713 713 715 718 721 721
Ważona ilośc akcji (mln) 721 533 534 534 642 716 717 711 713 762 774 718 721 721
Waluta CNY CNY CNY CNY CNY CNY CNY CNY CNY CNY CNY CNY CNY CNY